N-acetylcysteine capsule (DrugBank: Acetylcysteine, N-acetylcysteine)
17 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 1 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
19 | ライソゾーム病 | 0 |
20 | 副腎白質ジストロフィー | 0 |
34 | 神経線維腫症 | 0 |
49 | 全身性エリテマトーデス | 0 |
51 | 全身性強皮症 | 0 |
58 | 肥大型心筋症 | 0 |
85 | 特発性間質性肺炎 | 0 |
90 | 網膜色素変性症 | 0 |
94 | 原発性硬化性胆管炎 | 0 |
111 | 先天性ミオパチー | 0 |
164 | 眼皮膚白皮症 | 0 |
193 | プラダー・ウィリ症候群 | 0 |
233 | ウォルフラム症候群 | 0 |
298 | 遺伝性膵炎 | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02212678 (ClinicalTrials.gov) | September 2014 | 4/8/2014 | Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Parkinson Disease | Drug: N-acetylcysteine capsule | University of Minnesota | Parkinson's Disease Society of the United Kingdom | Completed | 18 Years | N/A | All | 8 | Phase 2 | United States |